Health Economics
We develop robust health economic models to assess the value and cost-effectiveness of pharmaceutical and healthcare innovations, supporting evidence-based reimbursement and market access decisions.
- We combine in-depth knowledge of the Canadian healthcare system with advanced modelling techniques to generate rigorous economic evidence that addresses payer-specific requirements.
- We develop tailored costing tools, including cost-of-illness studies and cost calculators, to quantify economic impact, estimate potential savings, and support informed decision-making.
- Experts in health economics – Our team brings extensive experience in health economic modelling and pharmacoeconomic analysis, tailored to the requirements of Canadian HTA bodies and payers.
- Deep Understanding of Payer Perspectives – We align economic evaluations with the perspectives and requirements of CDA-AMC, INESSS, provincial and private payers, including the societal perspective required by INESSS.
- Economic Tools to Support Payer Negotiations – We develop customized tools to assess the economic impact of reimbursement scenarios and to support informed negotiations with Canadian payers.
